RO7296682 is an experimental cancer therapy. RO7296682 is a placeholder name used until the completion of the clinical trial.
This study will investigate the safety and effectiveness of RO7296682 for treating advanced kidney cancer.
Different doses of RO7296682 will be used to determine the dosage with the greatest benefit and fewest side effects.
- Cancer has spread or cannot be removed by surgery
- Must have received at least one other treatment for kidney cancer
- No previous treatment with immunotherapy
Additional eligibility criteria will apply. Please speak to your doctor.
Find out more about this study.
|Hospital / Cancer Centre||Principal Investigator||Location||Trial Status|
|Hospital / Cancer CentreBC Cancer Agency - Vancouver||Principal Investigator||LocationVancouver, British Columbia||Trial StatusNot yet recruiting|
|Hospital / Cancer CentreThe Ottawa Hospital Cancer Centre||Principal Investigator||LocationOttawa, Ontario||Trial StatusNot yet recruiting|
|Hospital / Cancer CentrePrincess Margaret Cancer Centre||Principal Investigator||LocationToronto, Ontario||Trial StatusNot yet recruiting|